Management of patients co-infected with HBV and HCV

References

• Gaeta GB, Stornaiuolo G, Precone DF et al. Epidemiological and clinical burden of chronic hepatitis-B virus/hepatitis C virus infection. A multicenter Italian study. J. Hepatol.39, 1036–1041 (2003).
   PubMed Web of Science ®Google Scholar
• Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M. Risk factors for mono-infections and co-infections with HIV, hepatitis-B and hepatitis C viruses in northern Spanish prisoners. Epidemiol. Infect.123, 95–102 (1999).
   PubMed Web of Science ®Google Scholar
• Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Co-infections by HIV, hepatitis-B and hepatitis C in imprisoned injecting drug users. Eur. J. Epidemiol.15, 699–704 (1999).
   PubMed Web of Science ®Google Scholar
• Aroldi A, Lampertico P, Montagnino G et al. Natural history of hepatitis-B and C in renal allograft recipients. Transplantation79, 1132–1136 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM. Hepatitis-B and C virus co-infection in The TREAT Asia HIV Observational Database. J. Gastroenterol. Hepatol.22, 1510–1518 (2007).
   PubMed Web of Science ®Google Scholar
• Crespo J, Lozano JL, de la Cruz F et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis-B. Am. J. Gastroenterol.89, 1147–1151 (1994).
   PubMed Web of Science ®Google Scholar
• Fattovich G, Tagger A, Brollo L et al. Hepatitis C virus infection in chronic hepatitis-B virus carriers. J. Infect. Dis.163, 400–402 (1991).
   PubMed Web of Science ®Google Scholar
• Chan CY, Lee SD, Wu JC et al. Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. Scand. J. Infect. Dis.23, 421–424 (1991).
   PubMed Web of Science ®Google Scholar
• Liaw Y-F, Yeh-C-T, Tsai S-L. Impact of acute hepatitis-B virus superinfection on chronic hepatitis C virus infection. Am. J. Gastroenterol.95, 2978–2980 (2000).
   PubMed Web of Science ®Google Scholar
• Raimondo G, Allain JP, Brunetto MR et al. Statements from the Taormina expert meeting on occult hepatitis-B virus infection. J. Hepatol.49, 652–657 (2008).
   PubMed Web of Science ®Google Scholar
• Liaw YF. Hepatitis C virus superinfection in patients with chronic hepatitis-B virus infection. J. Gastroenterol.37(Suppl. 13), 65–68 (2002).
   PubMed Web of Science ®Google Scholar
• Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis-B virus infection. Gastroenterology126, 1024–1029 (2004).
   PubMed Web of Science ®Google Scholar
• Guido M, Rugge M, Colombari R, Cecchetto A, Scarpa A, Cadrobbi P. Prompt hepatitis C virus suppression following hepatitis-B virus superinfection in chronic untreated hepatitis C. Ital. J. Gastroenterol. Hepatol.30, 414–417 (1998).
   PubMed Web of Science ®Google Scholar
• Wietzke P, Schott P, Braun F, Mihm S, Ramadori G. Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis-B virus superinfection. Liver19, 348–353 (1999).
   PubMedGoogle Scholar
• Sagnelli E, Coppola N, Messina V et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction and clinical course. Hepatology36, 1285–1291 (2002).
   PubMed Web of Science ®Google Scholar
• Coffin CS, Mulrooney-Cousins PM, Lee SS, Michalak TI, Swain MG. Profound suppression of chronic hepatitis C following superinfection with hepatitis-B virus. Liver Int.27, 722–726 (2007).
   PubMed Web of Science ®Google Scholar
• Mimms LT, Mosley JW, Hollinger FB et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis-B virus infection. BMJ307, 1095–1097 (1993).
   PubMed Web of Science ®Google Scholar
• Chu CM, Liaw YF. Simultaneous acute hepatitis-B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C. Clin. Infect. Dis.20, 703–705 (1995).
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis-B, C, and δ viruses in patients with chronic hepatitis. Hepatology32, 1106–1110 (2000).
   PubMed Web of Science ®Google Scholar
• Alberti A, Clumeck N, Collins S et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis-B and C in HIV co-infected patients. J. Hepatol.42, 615–624 (2005).
   PubMed Web of Science ®Google Scholar
• Lee LP, Dai CY, Chuang WL et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis-B and C-co-infected patients. J. Gastroenterol. Hepatol.22, 515–517 (2007).
   PubMed Web of Science ®Google Scholar
• Zarski JP, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis-B and C viruses. J. Hepatol.28, 27–33 (1998).
   PubMed Web of Science ®Google Scholar
• Benvegnu L, Fattovich G, Noventa F et al. Concurrent hepatitis-B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer74, 2442–2448 (1994).
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer85, 2132–2137 (1999).
   PubMed Web of Science ®Google Scholar
• Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis-B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer75, 347–354 (1998).
   PubMed Web of Science ®Google Scholar
• Benvegnu L, Alberti A. Patterns of hepatocellular carcinoma development in hepatitis-B virus and hepatitis C virus related cirrhosis. Antiviral Res.52, 199–207 (2001).
   PubMed Web of Science ®Google Scholar
• Huo TI, Huang YH, Hsia CY et al. Characteristics and outcome of patients with dual hepatitis-B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int.29(5), 767–773 (2008).
   PubMed Web of Science ®Google Scholar
• Fan CL, Wei L, Jiang D et al. Spontaneous viral clearance after 6–21 years of hepatitis B and C viruses co-infection in high HBV endemic area. World J. Gastroenterol.9, 2012–2016 (2003).
   PubMed Web of Science ®Google Scholar
• Shiratori Y, Shiina S, Zhang PY et al. Does dual infection by hepatitis-B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer80, 2060–2067 (1997).
   PubMed Web of Science ®Google Scholar
• Fukuda R, Ishimura N, Hamamoto S et al. Co-infection by serologically-silent hepatitis-B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J. Med. Virol.63, 220–227 (2001).
   PubMed Web of Science ®Google Scholar
• Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis-B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med.341, 22–26 (1999).
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and ‘silent’ HBV co-infection: two main risk factors for a more severe liver disease. J. Med. Virol.64, 350–355 (2001).
   PubMed Web of Science ®Google Scholar
• Giannini E, Ceppa P, Botta F et al. Previous hepatitis-B virus infection is associated with worse disease stage and occult hepatitis-B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int.23, 12–18 (2003).
   PubMed Web of Science ®Google Scholar
• Chu CM, Sheen IS, Liaw YF. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis-B virus-hepatitis C virus co-infection. Scand. J. Gastroenterol.39, 778–782 (2004).
   PubMed Web of Science ®Google Scholar
• Raimondo G, Brunetto MR, Pontisso P et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis-B/hepatitis C virus-co-infected patients. Hepatology43, 100–107 (2006).
   PubMed Web of Science ®Google Scholar
• Alberti A, Pontisso P, Chemello L et al. The interaction between hepatitis-B virus and hepatitis C virus in acute and chronic liver disease. J. Hepatol.22, 38–41 (1995).
   PubMed Web of Science ®Google Scholar
• Coppola N, Pisapia R, Tonziello G et al. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis-B and C virus co-infection. Antivir. Ther.13, 307–318 (2008).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Íñigo E, Bartolomé J, Movilla-Ortiz N et al. Hepatitis C virus (HCV) and hepatitis-B virus (HBV) can co-infect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J. Virol.79, 15578–15581 (2005).
   PubMed Web of Science ®Google Scholar
• Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis-B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol.67, 5823–5832 (1993).
   PubMed Web of Science ®Google Scholar
• Chen S-Y, Kao C-F, Chen C-M et al. Mechanisms for inhibition of hepatitis-B virus gene expression and replication by hepatitis C virus core protein. J. Biol. Chem.278, 591–607 (2003).
   PubMed Web of Science ®Google Scholar
• Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis-B virus enhancer 1 and 2 by hepatitis C virus core protein. J. Hepatol.37, 855–862 (2002).
   PubMed Web of Science ®Google Scholar
• Chu CJ, Lee SD. Hepatitis-B virus/hepatitis C virus co-infection: epidemiology, clinical features, viral interactions and treatment. J. Gastroenterol. Hepatol.23, 512–520 (2008).
   PubMed Web of Science ®Google Scholar
• Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis-B. Am. J. Pathol.156, 1117–1132 (2000).
   PubMed Web of Science ®Google Scholar
• Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis-B and C dually infected patients. Hepatology37, 568–576 (2003).
   PubMed Web of Science ®Google Scholar
• Guptan RC, Thakur V, Raina V, Sarin SK. α-interferon therapy in chronic hepatitis due to active dual infection with hepatitis-B and C viruses. J. Gastroenterol. Hepatol.14, 893–898 (1999).
   PubMed Web of Science ®Google Scholar
• Liaw YF, Chien RN, Lin SM et-al.Response of patients with dual hepatitis-B virus and C virus infection to interferon therapy. J. Interferon Cytokine Res.17, 449–452 (1997).
   PubMed Web of Science ®Google Scholar
• Villa E, Grottola A, Buttafoco P et al. High doses of α-interferon are required in chronic hepatitis due to co-infection with hepatitis-B virus and hepatitis C virus: long term results of a prospective randomized trial. Am. J. Gastroenterol.96, 2973–2977 (2001).
   PubMed Web of Science ®Google Scholar
• Weltman MD, Brotodihardjo A, Crewe EB et al. Co-infection with hepatitis-B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-α treatment. J. Viral Hepat.2, 39–45 (1995).
   PubMed Web of Science ®Google Scholar
• Potthoff A, Wedemeyer H, Boecher WO et al. The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection. J. Hepatol.49, 688–694 (2008).
   PubMed Web of Science ®Google Scholar
• Saitta C, Pontisso P, Brunetto MR et al. Virological profiles in hepatitis-B virus/hepatitis C virus co-infected patients under interferon plus ribavirin therapy. Antivir. Ther.11, 931–934 (2006).
   PubMed Web of Science ®Google Scholar
• Senturk H, Tahan V, Canbakan B et al. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. Neth. J. Med.66, 191–195 (2008).
   PubMed Web of Science ®Google Scholar
• Liu CJ, Chuang WL, Lee CM et al. Peginterferon α-2a plus ribavirin for the treatment of dual chronic infection with hepatitis-B and C viruses. Gastroenterology136(2), 496–504 (2008).
   PubMed Web of Science ®Google Scholar
• Marrone A, Zampino R, D’Onofrio M, Ricciotti R, Ruggiero G, Utili R. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection. J. Hepatol.41, 1064–1065 (2004).
   PubMed Web of Science ®Google Scholar
• Chuang WL, Dai CY, Chang WY et al. Viral interaction and responses in chronic hepatitis C and B co-infected patients with interferon-α plus ribavirin combination therapy. Antivir. Ther.10, 125–133 (2005).
   PubMed Web of Science ®Google Scholar
• Hung CH, Lee CM, Lu SN et al. Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J. Gastroenterol. Hepatol.20, 727–732 (2005).
   PubMed Web of Science ®Google Scholar
• Utili R, Zampino R, Bellopede P et al. Dual or single hepatitis-B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood94, 4046–4052 (1999).
   PubMed Web of Science ®Google Scholar
• de Franchis R, Hadengue A, Lau G et al. EASL International Consensus Conference on Hepatitis-B. 13–14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J. Hepatol.39(Suppl. 1), S3–S25 (2003).
   PubMed Web of Science ®Google Scholar
• Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology49, 1335–1374 (2008).
   Web of Science ®Google Scholar
• Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology39, 1147–1171 (2004).
   PubMed Web of Science ®Google Scholar
• Liaw YF, Leung N, Guan R et al. Asian–Pacific consensus statement on the management of chronic hepatitis-B: a 2005 update. Liver Int.25, 472–489 (2005).
   PubMed Web of Science ®Google Scholar
• Lok AS. Navigating the maze of hepatitis-B treatments. Gastroenterology132, 1586–1594 (2007).
   PubMed Web of Science ®Google Scholar